Información del artículo
El Texto completo está disponible en PDF
Referencias
[1.]
L.C. Coates, R.R. Anderson, O. Fitzgerald, A.B. Gottlieb, S.G. Kelly, E. Lubrano, et al.
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review.
J Rheumatol, 35 (2008), pp. 1438-1442
[2.]
B.J. Nickoloff.
Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediate skin disease Viewpoint.
J Cutan Pathol, 28 (2001), pp. 57-64
[3.]
V. Chaturvedi, M. Cesnjaj, P. Bacon, J. Panella, D. Choubey, M.O. Diaz, et al.
Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes.
Am J Pathol, 162 (2003), pp. 161-170
[4.]
R. Zenz, R. Eferl, C. Scheinecker, K. Redlich, J. Smolen, H.B. Schonthaler, et al.
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease.
Arthritis Res Ther, 10 (2008), pp. 201
[5.]
R. Zenz, E.F. Waqner.
Jun signalling in the epideremis: From developmental defects to psoriasis and skin tumors.
Int J Biochem Cell Biol, 38 (2006), pp. 1043-1049
[6.]
P. Serznig, M. Seifert, W. Tilgen, J. Reichrath.
Peroxisome proliferatoractivated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Am J Clin Dermatol, 9 (2008), pp. 15-31
[7.]
V.C. Njar, L. Gediva, P. Purushottamachar, P. Chopra, T.S. Vasaitis, A. Khandelwal, et al.
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
Bioorg Med Chem, 14 (2006), pp. 4323-4340
[8.]
P. McCaffery, C. Simons.
Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity.
Curr Pharm Des, 13 (2007), pp. 3020-3037
[9.]
R.L. Thangapazham, A. Sharma, R.K. Maheshwari.
Beneficial role of curcumin in skin diseases.
Adv Exp Med Biol, 595 (2007), pp. 343-357
[10.]
C.H. Hsu, A.L. Cheng.
Clinical studies with curcumin.
Adv Exp Med Biol, 595 (2007), pp. 471-480
[11.]
A.S. Boyd.
Thiazolidinediones in dermatology.
Int J Dermatol, 46 (2007), pp. 557-563
[12.]
J. Reichrath, B. Lehmann, C. Carlberg, J. Varani, C.C. Zouboulis.
Vitamins as hormones.
Horm Metab Res, 39 (2007), pp. 71-84
[13.]
K.V. Paghdal, R.A. Schwartz.
Sirolimus (rapamycin): from the soil of Easter Island to a bright future.
JAm Acad Dermatol, 57 (2007), pp. 1046-1050
[14.]
S. Sano, K.S. Chan, J. DiGiovanni.
Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases.
J Dermatol Sci, 50 (2008), pp. 1-14
[15.]
M. Kamstrup, A. Faurschou, R. Gniadecki, H.C. Wulf.
Epidermal stem cells-role in normal, wounded adn pathological psoriatic and cancer skin.
Curr Stem Cell Res Ther, 3 (2008), pp. 146-150
[16.]
A.A. Gómez.
Psoriasis y cancer.
Rev Colomb Cancerol, 12 (2008), pp. 150-155
Copyright © 2009. Instituto Nacional de Cancerología
